NO303731B1 - Imidazodiazepiner - Google Patents

Imidazodiazepiner

Info

Publication number
NO303731B1
NO303731B1 NO950999A NO950999A NO303731B1 NO 303731 B1 NO303731 B1 NO 303731B1 NO 950999 A NO950999 A NO 950999A NO 950999 A NO950999 A NO 950999A NO 303731 B1 NO303731 B1 NO 303731B1
Authority
NO
Norway
Prior art keywords
formula
lower alkyl
atom
imidazodiazepine
imidazodiazepines
Prior art date
Application number
NO950999A
Other languages
English (en)
Norwegian (no)
Other versions
NO950999D0 (no
NO950999L (no
Inventor
Thierry Godel
Walter Hunkeler
Heinz Stadler
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO950999D0 publication Critical patent/NO950999D0/no
Publication of NO950999L publication Critical patent/NO950999L/no
Publication of NO303731B1 publication Critical patent/NO303731B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO950999A 1994-03-16 1995-03-15 Imidazodiazepiner NO303731B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH78394 1994-03-16
CH1095 1995-01-03

Publications (3)

Publication Number Publication Date
NO950999D0 NO950999D0 (no) 1995-03-15
NO950999L NO950999L (no) 1995-09-18
NO303731B1 true NO303731B1 (no) 1998-08-24

Family

ID=25683249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950999A NO303731B1 (no) 1994-03-16 1995-03-15 Imidazodiazepiner

Country Status (27)

Country Link
US (1) US5665718A (fr)
EP (1) EP0672666B1 (fr)
JP (1) JP2690282B2 (fr)
KR (1) KR100214800B1 (fr)
CN (1) CN1036995C (fr)
AT (1) ATE203536T1 (fr)
AU (1) AU679608B2 (fr)
BG (1) BG62210B1 (fr)
CA (1) CA2143246C (fr)
CZ (1) CZ288594B6 (fr)
DE (1) DE59509432D1 (fr)
DK (1) DK0672666T3 (fr)
ES (1) ES2160646T3 (fr)
FI (1) FI112487B (fr)
GR (1) GR3037019T3 (fr)
HU (1) HU219987B (fr)
IL (1) IL112955A (fr)
IS (1) IS4273A (fr)
LV (1) LV11327B (fr)
MA (1) MA23479A1 (fr)
NO (1) NO303731B1 (fr)
NZ (1) NZ270685A (fr)
PH (1) PH31443A (fr)
PT (1) PT672666E (fr)
RO (1) RO117698B1 (fr)
RU (1) RU2139873C1 (fr)
SK (1) SK33995A3 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349100B (en) * 1994-11-11 1999-01-01 Hoffmann La Roche Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines
US5905176A (en) * 1998-08-28 1999-05-18 Eastman Chemical Company Process for the production of cyclobutyl halides
TR200103237T2 (tr) * 1999-05-12 2002-04-22 F. Hoffmann-La Roche Ag İmidazodiazepin türevi
US7160880B1 (en) 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
RU2199309C1 (ru) * 2001-12-29 2003-02-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство нобрассит седативного и анксиолитического действия
US20060065608A1 (en) * 2004-09-29 2006-03-30 Choate Chris E Process and apparatus for generating useful biomass from organic waste streams
CA2594946A1 (fr) * 2005-01-19 2006-07-27 Merck & Co., Inc Carbinamines tertiaires incluant des heterocycles substitues, agissant en tant qu'inhibiteurs de la beta-secretase et utilisees dans le traitement de la maladie d'alzheimer
WO2006078576A2 (fr) * 2005-01-19 2006-07-27 Merck & Co., Inc. Inhibiteurs de la $g(b)-secretase d'aminomethyle dans le traitement de la maladie d'alzheimer
EP1888594A2 (fr) * 2005-05-16 2008-02-20 Wisys Technology Foundation, Inc. Agents gabaergiques utilises dans le traitement de troubles de la memoire
GB0613693D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
CA2657347C (fr) 2006-07-10 2014-11-18 Paion Uk Limited Sels de benzodiazepine et leurs formes polymorphes a action breve
WO2009024325A2 (fr) * 2007-08-20 2009-02-26 Evotec Neurosciences Gmbh Traitement de troubles du sommeil
WO2009024324A2 (fr) * 2007-08-20 2009-02-26 Evotec Neurosciences Gmbh Traitement des troubles du sommeil
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
RU2503681C2 (ru) * 2008-09-30 2014-01-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Новое конденсированное производное аминодигидротиазина
EP2450039A1 (fr) 2010-11-08 2012-05-09 PAION UK Ltd. Régime de dosage permettant la sédation avec CNS 7056 (Remimazolam)
NZ702063A (en) 2012-05-22 2016-11-25 Paion Uk Ltd Compositions comprising short-acting benzodiazepines
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
HRP20181052T1 (hr) 2013-09-06 2018-09-07 Aurigene Discovery Technologies Limited Derivati 1,2,4-oksadiazola kao imunomodulatori
NZ734650A (en) * 2015-03-10 2023-07-28 Aurigene Oncology Ltd 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
EP3267985A4 (fr) * 2015-03-10 2018-07-25 Aurigene Discovery Technologies Limited Composés 3-substitué -1,2,4-oxadiazole et thiadiazole utilisés comme immunomodulateurs
EP3442539B1 (fr) 2016-04-14 2025-04-09 Paion UK Limited Benzodiazépines à usage nasal et inhalées par voie orale
WO2019061324A1 (fr) 2017-09-29 2019-04-04 Curis Inc. Formes cristallines d'immunomodulateurs
IL273896B2 (en) 2017-10-11 2025-08-01 Aurigene Oncology Ltd Crystalline forms of 3-substituted 1,2,4-oxadiazole
AU2018360386B2 (en) 2017-11-03 2023-11-09 Aurigene Oncology Limited Dual inhibitors of TIM-3 and PD-1 pathways
CN111386128A (zh) 2017-11-06 2020-07-07 奥瑞基尼探索技术有限公司 用于免疫调节的联合疗法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA755418B (en) * 1974-09-11 1977-06-29 Hoffmann La Roche Diazepine derivatives
IL49161A (en) * 1975-08-07 1982-04-30 Sparamedica Ag Imidazo(1,5-a)(1,4)-diazepine derivatives,their manufacture and pharmaceutical compositions containing them
AT361486B (de) * 1975-08-07 1981-03-10 Hoffmann La Roche Verfahren zur herstellung von neuen imidazo(1,5 -a) (1,4)diazepinverbindungen, ihren salzen und optisch aktiven formen
FI63033C (fi) * 1977-07-21 1983-04-11 Boehringer Sohn Ingelheim Foerfarande foer framstaellning av anxiolytiska tranquilliserande sedativa och/eller neuroleptiska substituerade 1-piperazinyl-4h-s-triazolo(3,4-c)tieno(2,3-e)-1,4-diazepiner
DK151808C (da) * 1982-11-16 1988-06-20 Ferrosan As Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater
FI850191A7 (fi) * 1984-01-19 1985-07-20 Hoffmann La Roche Imidatsodiatsepiini-johdannaisia.
AU587802B2 (en) * 1985-03-08 1989-08-31 Ferrosan A/S Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
DK476885D0 (da) * 1985-10-17 1985-10-17 Ferrosan As Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf
US4622320A (en) * 1985-05-17 1986-11-11 As Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
US4904654A (en) * 1989-07-26 1990-02-27 Merck & Co., Inc. 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine
US4939139A (en) * 1989-07-26 1990-07-03 Merck & Co., Inc. 7-chloro-5,6-dihydro-3-(5-(1,2-dihydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5A][1,4]benzodiazepine

Also Published As

Publication number Publication date
CN1111632A (zh) 1995-11-15
IL112955A (en) 1998-02-08
IL112955A0 (en) 1995-06-29
HUT71817A (en) 1996-02-28
AU1476095A (en) 1995-09-28
FI951251A7 (fi) 1995-09-17
JP2690282B2 (ja) 1997-12-10
CN1036995C (zh) 1998-01-14
LV11327B (en) 1996-10-20
PT672666E (pt) 2002-01-30
FI951251A0 (fi) 1995-03-16
EP0672666B1 (fr) 2001-07-25
ES2160646T3 (es) 2001-11-16
BG62210B1 (bg) 1999-05-31
FI112487B (fi) 2003-12-15
NO950999D0 (no) 1995-03-15
LV11327A (lv) 1996-06-20
CZ288594B6 (cs) 2001-07-11
DE59509432D1 (de) 2001-08-30
PH31443A (en) 1998-11-03
US5665718A (en) 1997-09-09
RU2139873C1 (ru) 1999-10-20
NZ270685A (en) 1996-05-28
KR100214800B1 (ko) 1999-08-02
HU219987B (hu) 2001-10-28
MA23479A1 (fr) 1995-10-01
CA2143246C (fr) 2000-08-22
GR3037019T3 (en) 2002-01-31
RO117698B1 (ro) 2002-06-28
EP0672666A2 (fr) 1995-09-20
JPH07258260A (ja) 1995-10-09
HU9500743D0 (en) 1995-04-28
RU95103921A (ru) 1996-12-10
CA2143246A1 (fr) 1995-09-17
SK33995A3 (en) 1995-10-11
CZ66395A3 (en) 1995-10-18
NO950999L (no) 1995-09-18
KR950032199A (ko) 1995-12-20
BG99505A (en) 1996-01-31
DK0672666T3 (da) 2001-11-12
ATE203536T1 (de) 2001-08-15
AU679608B2 (en) 1997-07-03
IS4273A (is) 1995-09-17
EP0672666A3 (fr) 1995-11-08

Similar Documents

Publication Publication Date Title
ATE203536T1 (de) Imidazodiazepine
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
ATE31307T1 (de) Benzofuran- und benzopyrancarboxamid-derivate.
ES2068413T3 (es) Derivados de 4-fenilftalazina.
ES2060970T3 (es) Nuevos derivados de benzonaftiridina-1,8, su preparacion y las composiciones que les contienen.
ES2046229T3 (es) Composicion antiulcerosa.
DK0623131T3 (da) Alkylderivater af trazodon med CNS-aktivitet
ES2077176T3 (es) Composiciones de goma.
NO900732L (no) Arylalkylaminforbindelser.
GR1000887B (el) Νεα παραγωγα σπιροφουρανης.
DE69023045D1 (de) Carboxamidderivate.
GR3008034T3 (fr)
SE8103598L (sv) Antiinflammatoriska medel for yttre anvendning
ES479378A1 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina.
FR2363629A1 (fr) Activateurs pour percomposes
DK158002C (da) Pyridooe2,1-baaquinazolin-derivater, farmaceutisk e praeparater indeholdende disse og anvendelse af disse
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
FI943360L (fi) Propoksibentseenijohdannaisia
FI900796A0 (fi) Aralkylaminfoereningar.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002